249 related articles for article (PubMed ID: 3361379)
1. Clinical and immunologic responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18- to 23-month-old children.
Claesson BA; Trollfors B; Lagergard T; Taranger J; Bryla D; Otterman G; Cramton T; Yang Y; Reimer CB; Robbins JB
J Pediatr; 1988 May; 112(5):695-702. PubMed ID: 3361379
[TBL] [Abstract][Full Text] [Related]
2. Persistence of serum antibodies elicited by Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants vaccinated at 3, 5 and 12 months of age.
Claesson BA; Schneerson R; Lagergård T; Trollfors B; Taranger J; Johansson J; Bryla D; Robbins JB
Pediatr Infect Dis J; 1991 Aug; 10(8):560-4. PubMed ID: 1891286
[TBL] [Abstract][Full Text] [Related]
3. Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates.
Schneerson R; Robbins JB; Parke JC; Bell C; Schlesselman JJ; Sutton A; Wang Z; Schiffman G; Karpas A; Shiloach J
Infect Immun; 1986 May; 52(2):519-28. PubMed ID: 3516876
[TBL] [Abstract][Full Text] [Related]
4. Impaired antibody response to Haemophilus influenzae type b polysaccharide and low IgG2 and IgG4 concentrations in Apache children.
Siber GR; Santosham M; Reid GR; Thompson C; Almeido-Hill J; Morell A; deLange G; Ketcham JK; Callahan EH
N Engl J Med; 1990 Nov; 323(20):1387-92. PubMed ID: 2233905
[TBL] [Abstract][Full Text] [Related]
5. Serum antibody responses of juvenile and infant rhesus monkeys injected with Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-protein conjugates.
Schneerson R; Robbins JB; Chu C; Sutton A; Vann W; Vickers JC; London WT; Curfman B; Hardegree MC; Shiloach J
Infect Immun; 1984 Sep; 45(3):582-91. PubMed ID: 6332076
[TBL] [Abstract][Full Text] [Related]
6. Duration of serum antibodies elicited by Haemophilus influenzae type b capsular polysaccharide alone or conjugated to tetanus toxoid in 18- to 23-month-old children.
Claesson BA; Schneerson R; Trollfors B; Lagergård T; Taranger J; Robbins JB
J Pediatr; 1990 Jun; 116(6):929-31. PubMed ID: 2348298
[No Abstract] [Full Text] [Related]
7. The acquisition of anti-pneumococcal capsular polysaccharide Haemophilus influenzae type b and tetanus toxoid antibodies, with age, in the UK.
Hazlewood M; Nusrat R; Kumararatne DS; Goodall M; Raykundalia C; Wang DG; Joyce HJ; Milford-Ward A; Forte M; Pahor A
Clin Exp Immunol; 1993 Aug; 93(2):157-64. PubMed ID: 8348740
[TBL] [Abstract][Full Text] [Related]
8. Suppression and modulation of cellular and humoral immune responses to Haemophilus influenzae type B (Hib) conjugate vaccine in hib-diphtheria-tetanus toxoids-acellular pertussis combination vaccines: a study in a rat model.
Mawas F; Newman G; Burns S; Corbel MJ
J Infect Dis; 2005 Jan; 191(1):58-64. PubMed ID: 15593004
[TBL] [Abstract][Full Text] [Related]
9. Further studies on the immunogenicity of Haemophilus influenzae type b and pneumococcal type 6A polysaccharide-protein conjugates.
Chu C; Schneerson R; Robbins JB; Rastogi SC
Infect Immun; 1983 Apr; 40(1):245-56. PubMed ID: 6601061
[TBL] [Abstract][Full Text] [Related]
10. Studies on Pneumococcus vaccine alone or mixed with DTP and on Pneumococcus type 6B and Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugates in two- to five-year-old children with sickle cell anemia.
Sarnaik S; Kaplan J; Schiffman G; Bryla D; Robbins JB; Schneerson R
Pediatr Infect Dis J; 1990 Mar; 9(3):181-6. PubMed ID: 2336298
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of Haemophilus influenzae type b conjugate vaccine in allogeneic bone marrow recipients.
Barra A; Cordonnier C; Preziosi MP; Intrator L; Hessel L; Fritzell B; Preud'homme JL
J Infect Dis; 1992 Nov; 166(5):1021-8. PubMed ID: 1402013
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial to assess immunogenicity and safety of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in infants.
Marchant CD; Miller JM; Marshall GS; Blatter M; Aris E; Friedland LR; Boutriau D;
Pediatr Infect Dis J; 2010 Jan; 29(1):48-52. PubMed ID: 20035207
[TBL] [Abstract][Full Text] [Related]
13. Clinical and immunologic responses to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants injected at 3, 5, 7, and 18 months of age.
Parke JC; Schneerson R; Reimer C; Black C; Welfare S; Bryla D; Levi L; Pavliakova D; Cramton T; Schulz D
J Pediatr; 1991 Feb; 118(2):184-90. PubMed ID: 1993943
[TBL] [Abstract][Full Text] [Related]
14. Qualitative and quantitative analyses of the antibody response elicited by Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugates in adults with IgG subclass deficiencies and frequent infections.
Avanzini MA; Björkander J; Söderström R; Söderström T; Schneerson R; Robbins JB; Hanson LA
Clin Exp Immunol; 1994 Apr; 96(1):54-8. PubMed ID: 8149666
[TBL] [Abstract][Full Text] [Related]
15. Hib antibody responses in infants following diphtheria, tetanus, acellular pertussis, and conjugated Haemophilus influenzae type b (Hib) combination vaccines with decreasing amounts of tetanus toxoid.
Bernstein HH; Seyferth ER
Vaccine; 2017 Dec; 35(48 Pt B):6707-6711. PubMed ID: 29054729
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a guinea pig model to assess interference in the immunogenicity of different components of a combination vaccine comprising diphtheria, tetanus and acellular pertussis (DTaP) vaccine and haemophilus influenzae type b capsular polysaccharide conjugate vaccine.
Gupta RK; Anderson R; Cecchini D; Rost B; Xu J; Gendreau K; Saroff DL; Marchant C; Siber GR
Biologicals; 1999 Jun; 27(2):167-76. PubMed ID: 10600208
[TBL] [Abstract][Full Text] [Related]
17. Antibodies against Haemophilus influenzae type b capsular polysaccharide and tetanus toxoid before and after a booster dose of the carrier protein nine years after primary vaccination with a protein conjugate vaccine.
Claesson BA; Trollfors B; Lagergård T; Knutsson N; Schneerson R; Robbins JB
Pediatr Infect Dis J; 2005 May; 24(5):463-4. PubMed ID: 15876951
[TBL] [Abstract][Full Text] [Related]
18. Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants.
Granoff DM; Anderson EL; Osterholm MT; Holmes SJ; McHugh JE; Belshe RB; Medley F; Murphy TV
J Pediatr; 1992 Aug; 121(2):187-94. PubMed ID: 1640282
[TBL] [Abstract][Full Text] [Related]
19. Safety and immunogenicity of a Haemophilus influenzae type B polysaccharide-tetanus toxoid conjugate vaccine combined with diphtheria, tetanus and pertussis vaccines in Thai infants.
Chotpitayasunondh T; Panpitpat C; Thisyakorn U; Furer E; Que JU; Hasler T; Cryz SJ
Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):91-8. PubMed ID: 9322290
[TBL] [Abstract][Full Text] [Related]
20. Antibody persistence for up to 5 years after a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine (HibMenCY-TT) given at 12-15 months of age.
Marshall GS; Blatter M; Marchant C; Aris E; Mesaros N; Miller JM
Pediatr Infect Dis J; 2013 Jun; 32(6):662-8. PubMed ID: 23340564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]